Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
High-Density Lipoprotein and Coronary Heart Disease
HTML
PDF
Details
Locations
Year:
2010
Type:
review
Source:
Journal of the American College of Cardiology
DOI:
10.1016/j.jacc.2010.01.008
Authors:
Pradeep Natarajan,
Kausik K. Ray,
Christopher P. Cannon
Institutions:
Brigham and Women's Hospital,
Harvard University,
University of Cambridge,
Thrombolysis in Myocardial Infarction Study Group
Language:
English
Topic:
Lipoproteins and Cardiovascular Health
Subfield:
Cardiology and Cardiovascular Medicine
Field:
Medicine
Domain:
Health Sciences
Keywords:
HDL cholesterol,
coronary artery disease,
cardiovascular risk,
lipid-lowering therapy
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
Bristol-Myers Squibb,
Eli Lilly and Company,
Pfizer,
AstraZeneca,
GlaxoSmithKline,
Merck,
Sanofi,
Iterion Therapeutics,
Novo Nordisk,
Daiichi Sankyo Europe
show all 10
OpenAlex ID:
W57115353
FWCI:
5.16
Cites:
289
Cited by:
267
Related to:
10